Cancer treatment

Cancer

Targeted Prevention of Radiation-Induced Oral Mucositis with Glutathione-Modified Liposome-Coated K12 Probiotics

Researchers from China National Nuclear Corporation 416 Hospital in Chengdu, China, have developed an innovative oral probiotic, K12@Lip@GSH, to overcome the challenges of radiation-induced oral mucositis (RIOM) in patients with head and neck cancer undergoing radiotherapy or chemotherapy. This groundbreaking approach encapsulates K12 within liposomes to enhance stability